+34%

est. 2Y upside i

HealthcareSeries D+

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms—the vast majority of which have never been explored by science—creating a database of chemical biodiversity: the library of life.

Rank

#1279

Sector

Biotechnology

Est. Liquidity

~3Y

Data Quality

Data: Medium

Equity upside is moderate (~34% expected over 2 years) but heavily burdened by $592M preference stack (59% of $1B valuation).

Last updated: July 19, 2026

Bull (20%)+69%

Exit multiple holds at 14.3x on $135.3M revenue (driven by pipeline milestones and IPO window), yielding $1.89B exit; after 20% dilution, common return ~69%.

Base (55%)+42%

Exit multiple compresses to 12x on $135.3M revenue, aligning with comp range; exit $1.62B; net of 20% dilution, common return ~42%.

Bear (25%)-12%

Exit multiple drops to 8x on $135.3M revenue, exit $1.08B; above $592M preference, so common return after dilution ~ -12% (preference overhang severe).

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

5920%

Total funding of $592M represents 59.2% of $1B valuation; common equity is only $408M, severely limiting upside for common holders.

Dilution Risk

high

With $70M revenue and high R&D spend, additional dilutive rounds within 2 years are likely; modeled 20% dilution.

Secondary Liquidity

none

No secondary market signal in data; liquidity likely only through IPO or M&A, with no near-term signals.

Questions to Ask at the Interview

Strategic questions based on Enveda's data — designed to show you've done your homework.

  • 1

    “How does Enveda's platform differentiate from Recursion or Exscientia in terms of data and scaling?”

  • 2

    “What are the key milestones for ENV-308 and ENV-6946 over the next 18 months, and how do they de-risk the business?”

  • 3

    “Given the high total funding ($592M) relative to valuation, how does management plan to achieve liquidity for common shareholders?”

Community

Valuation Sentiment

Our model estimates +34% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.